Ardian, Keensight Capital and Parquest Capital acquire Unither
Ardian, Keensight Capital and Parquest Capital have completed their acquisition of Unither, a pharmaceutical contract development manufacturing organisation (CDMO), alongside the company’s existing management team. Unither was acquired from a consortium led by Equistone Partners Europe. Unither is a specialist in blow-fill-seal (BFS) technology, which uses sterile unit doses